Frequency of EGFP+ cells in peripheral blood of secondary recipients
. | Weeks after transplantation . | . | . | . | . | ||||
|---|---|---|---|---|---|---|---|---|---|
| Mouse phenotype . | 4 . | 5 . | 6 . | 7 . | 10 . | ||||
| IL-5Tg-mock, % | 9.1 ± 2.79 | 10.4 ± 3.20 | 12.6 ± 2.16 | 10.6 ± 1.08 | 9.4 ± 2.44 | ||||
| IL-5Tg-F/P (1/10), % | 66.2 ± 1.99 | 20.5 ± 5.77 | 9.0 ± 3.81 | 5.3 ± 3.33 | 2.5 ± 0.92 | ||||
. | Weeks after transplantation . | . | . | . | . | ||||
|---|---|---|---|---|---|---|---|---|---|
| Mouse phenotype . | 4 . | 5 . | 6 . | 7 . | 10 . | ||||
| IL-5Tg-mock, % | 9.1 ± 2.79 | 10.4 ± 3.20 | 12.6 ± 2.16 | 10.6 ± 1.08 | 9.4 ± 2.44 | ||||
| IL-5Tg-F/P (1/10), % | 66.2 ± 1.99 | 20.5 ± 5.77 | 9.0 ± 3.81 | 5.3 ± 3.33 | 2.5 ± 0.92 | ||||
Data are shown as mean ± SD of percent of EGFP+ cells in each group. For IL-5Tg-mock cells, n=4; for IL-5Tg-F/P (1/10) mice, n=3 (except at 10 weeks, where n=2).